Amgen v TKT: Assessment of inventive concept is crucial for assessing infringement of biotechnology patents

ISSN： 1478-565X

Source： Journal of Commercial Biotechnology, Vol.11, Iss.3, 2005-04, pp. : 263-270

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biotechnology patents and morality

By Crespi R.S.

Trends in Biotechnology, Vol. 15, Iss. 4, 1997-04 ,pp. : 123-129

Elsevier

Access to resources Recommend Favorite

When is patent infringement not patent infringement? Merck v Integra and the ‘safe harbour’

By Boyd Karen I

Journal of Commercial Biotechnology, Vol. 13, Iss. 1, 2006-10 ,pp. : 37-42

Palgrave Macmillan Ltd

Access to resources Recommend Favorite

Biotechnology policy in European countries: An assessment

By Zechendorf Bernhard

Journal of Commercial Biotechnology, Vol. 10, Iss. 4, 2004-06 ,pp. : 340-351

Palgrave Macmillan Ltd

Access to resources Recommend Favorite

Assessing quality, content, and accessibility of web information about plant biotechnology

By Zawedde Barbara M.

International Journal of Biotechnology, Vol. 12, Iss. 3, 2012-11 ,pp. : 198-223

Inderscience Publishers

Access to resources Recommend Favorite

Safe biotechnology 9: values in risk assessment for the environmental application of microorganisms

By Doblhoff-Dier O.

Trends in Biotechnology, Vol. 17, Iss. 8, 1999-08 ,pp. : 307-311

Elsevier

Access to resources Recommend Favorite